2017
DOI: 10.1016/j.jcyt.2016.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Pretreatment with IL-1β enhances proliferation and chondrogenic potential of synovium-derived mesenchymal stem cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
1
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 43 publications
0
23
1
1
Order By: Relevance
“…Inflammation is thought to contribute to LF degeneration and hypertrophy. Reports have demonstrated that proinflammatory cytokines have a crucial relationship with chondrogenesis 22 , 23 . In addition, we previously demonstrated that each BMP receptor type was higher in the LF obtained from patients with LSS and segmental hypermobility 4 .…”
Section: Discussionmentioning
confidence: 99%
“…Inflammation is thought to contribute to LF degeneration and hypertrophy. Reports have demonstrated that proinflammatory cytokines have a crucial relationship with chondrogenesis 22 , 23 . In addition, we previously demonstrated that each BMP receptor type was higher in the LF obtained from patients with LSS and segmental hypermobility 4 .…”
Section: Discussionmentioning
confidence: 99%
“…Preconditioning with IL‐1β increases the expression levels of various cytokines including TNF‐α, IL‐6, IL‐8 and IL‐23A and chemokines such as CCL5, CCL20, CXCL1, CXCL3, CXCL5, CXCL6, CXCL10 and CXCL11, as well as adhesion molecules such as vascular cell adhesion molecule (VCAM)‐1, intercellular adhesion molecule (ICAM)‐1 and ICAM‐4 in MSCs, thus improving the migration ability of MSCs to the site of inflammation in vivo . In addition, IL‐1β pretreatment not only increases the proliferation but also up‐regulates the chondrogenic potential of synovial MSCs; however, high concentrations of IL‐1β exert adverse effects on synovial MSCs by reducing the adhesion ability and pluripotency . TGF‐β1, which can be released from the bone matrix, induces MSC migration into the remodelling sites and couples bone formation and resorption via the canonical SMADs signalling pathway or the non‐canonical signalling pathways involving AKT, ERK1/2, FAK and p38 .…”
Section: Trophic Factors and Cytokines For Regulation Of Msc Fatementioning
confidence: 99%
“…Considering stem cell therapy for OA and other joint diseases, pre-treatment or chondrogenic priming with KGN or an IL-6/Stat3 analogue, prior to the in vivo transplantation or loading onto a biomaterial scaffold, may be able to enhance the therapeutic efficacy of CSPC or MSC. [41,42] Furthermore, this study demonstrated that KGN injection could also mediate cartilage regeneration, suggesting the potential of KGN to be developed 8as clinically useful tablets. In line of this and even more importantly, the biosafety and pharmacological kinetics of the systemically and locally administrated KGN may have become the next issue to be addressed in further investigation in order to translate the small chemical to clinical application.…”
Section: Discussionmentioning
confidence: 74%